Delivery Order SPE2DB22D9209-SPE2DB25FL5TR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order utilizes firm fixed-price pricing and represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,186.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The award, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $33,402.60 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the...
- The Defense Logistics Agency (DLA) awarded a $11,134.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 30, 2025, for the supply of YF-VAX 1 dose vials. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at $499.9 million through November 2026. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. This firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of September 18, 2025. The contract carries no set-aside designation, and performance will be completed at the vendor's Park Ridge location. This delivery order...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its...
- The Defense Logistics Agency issued a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 Dose Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 16, 2025, and was awarded on August 25, 2025, without any set-aside designation. This delivery order represents an individual procurement action issued under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,209.50, is for the delivery of 1-dose vials of the YF-VAX vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue firm fixed-price orders for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
- SPE2DB22D9209Indefinite Delivery Contract
- SPE2DB22D9209-SPE2DB25FL5TRDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, with an ultimate completion date of September 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities nationwide. The company's robust portfolio of federal contract awards demonstrates consistent capability in delivering specialized pharmaceutical products, including vaccines and injections, to military health systems. This delivery order for YF-VAX vials supports the DLA's ongoing requirement to maintain adequate pharmaceutical inventory across military medical facilities and aligns with the company's established role as a primary pharmaceutical distributor for the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/2/25 |